Relationship between serum transforming growth factor β 1 concentrations and the duration of type 1 diabetes mellitus in children and adolescents

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Zorena, Katarzyna ^a   Raczyńska, Dorota ^b   Wiśniewski, Piotr ^b   Malinowska, Ewa ^b   Myśliwiec, Małgorzata ^b   Raczyńska, Krystyna ^b   Rachoń, Dominik ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; CYTOMETRIC BEAD ARRAY; DISEASE DURATION; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PEDIATRICS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINOPATHY; RISK FACTOR; SCHOOL CHILD; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; DIABETIC ANGIOPATHY; DISEASE COURSE; FLOW CYTOMETRY; PATHOPHYSIOLOGY; REGRESSION ANALYSIS; TIME;

ADOLESCENT; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; REGRESSION ANALYSIS; RISK FACTORS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84886546471     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/849457     Document Type: Article

References (30)

1. Patterson C. C., Gyürüs E., Rosenbauer J., Cinek O., Neu A., Schober E., Parslow R. C., Joner G., Svensson J., Castell C., Bingley P. J., Schoenle E., Jarosz-Chobot P., Urbonaité B., Rothe U., Krzisnik C., Ionescu-Tirgoviste C., Weets I., Kocova M., Stipancic G., Samardzic M., de Beaufort C. E., Green A., Dahlquist G. G., Soltész G., Trends in childhood type 1 diabetes incidence in Europe during 1989-2008: evidence of non-uniformity over time in rates of increase. Diabetologia 2012 55 8 2142 2147 10.1007/s00125-012-2571-8
2. Jarosz-Chobot P., Polanska J., Szadkowska A., Kretowski A., Bandurska-Stankiewicz E., Ciechanowska M., Deja G., Mysliwiec M., Peczynska J., Rutkowska J., Sobel-Maruniak A., Fichna P., Chobot A., Rewers M., Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025. Diabetologia 2011 54 3 508 515 2-s2.0-79953757810 10.1007/s00125-010-1993-4
3. Romero P., Salvat M., Fernández J., Baget M., Martinez I., Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients. Journal of Diabetes and its Complications 2007 21 2 93 100 2-s2.0-33847315744 10.1016/j.jdiacomp.2006.04.001 (Pubitemid 46321521)
4. De Almeida Salgado P. P. C., Silva I. N., Vieira É. C., Silva A. C. S. E., Risk factors for early onset of diabetic nephropathy in pediatric type 1 diabetes. Journal of Pediatric Endocrinology and Metabolism 2010 23 12 1311 1320 2-s2.0-79955498642 10.1515/jpem.2010.205
5. Cheung N., Rogers S. L., Donaghue K. C., Jenkins A. J., Tikellis G., Wong T. Y., Retinal arteriolar dilation predicts retinopathy in adolescents with type 1 diabetes. Diabetes Care 2008 31 9 1842 1846 2-s2.0-56149120272 10.2337/dc08-0189
6. Moser J. T., Langdon D. R., Finkel R. S., Ratcliffe S. J., Foley L. R., Andrews-Rearson M. L., Murphy K. M., Lipman T. H., The evaluation of peripheral neuropathy in youth with type 1 diabetes. Diabetes Research and Clinical Practice 2013 100 1
7. Roy S., Trudeau K., Roy S., Behl Y., Dhar S., Chronopoulos A., New insights into hyperglycemia-induced molecular changes in microvascular cells. Journal of Dental Research 2010 89 2 116 127 2-s2.0-75649149828 10.1177/0022034509355765
8. Elbarbary N. S., El-Kabarity R. H., Desouky E. D., Cochleopathy in Egyptian adolescents with Type 1 diabetes mellitus. International Journal of Pediatric Otorhinolaryngology 2012 76 11 1558 1564 10.1016/j.ijporl.2012.07.010
9. Daniels M., Dubose S. N., Maahs D. M., Beck R. W., Fox L. A., Gubitosi-Klug R., Laffel L. M., Miller K. M., Speer H., Tamborlane W. V., Tansey M. J., Factors associated with microalbuminuria in 7,549 children and adolescents with Type 1 diabetes in the T1D exchange clinic registry. Diabetes Care 2013 2013 10.2337/dc12-2192
10. Kumar K. M. P., Krishna P., Reddy S. C., Gurappa M., Aravind S. R., Munichoodappa C., Incidence of type 1 diabetes mellitus and associated complications among children and young adults: results from Karnataka Diabetes Registry 1995-2008. Journal of the Indian Medical Association 2008 106 11 708 711 2-s2.0-65449129587
11. Griebsch I., Coast J., Brown J., Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health. Pediatrics 2005 115 5 e600 e614 2-s2.0-25144481018 10.1542/peds.2004- 2127 (Pubitemid 43852793)
12. Zorena K., Myśliwska J., Myśliwiec M., Balcerska A., Lipowski P., Raczyńska-Woźniak D., Raczyńska K., Modulatory factors responsible for neoangiogenesis in young patients with long-standing diabetes mellitus type 1. Recent Patents on Endocrine Metabolic & Immune Drug Discovery 2009 3 2 144 149 10.2174/187221409788452381
13. Amin R., Widmer B., Prevost A. T., Schwarze P., Cooper J., Edge J., Marcovecchio L., Neil A., Dalton R. N., Dunger D. B., Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 2008 336 7646 697 701 2-s2.0-41649115847 10.1136/bmj.39478.378241.BE (Pubitemid 351481211)
14. Raczyńska K., Zorena K., Myśliwska J., Myśliwiec M., Raczyńska-Woźniak D., Balcerska A., Analysis of the pro-angiogenic factor influencing the development of retinopathy in children with diabetes mellitus type 1. Polish Journal of Environmental Studies 2008 17 132 136
15. Schiött Å., Sjögren H. O., Lindvall M., The three isoforms of transforming growth factor- β co-stimulate rat T cells and inhibit lymphocyte apoptosis. Scandinavian Journal of Immunology 1998 48 4 371 378 2-s2.0-0031781378 10.1046/j.1365-3083.1998.00405.x (Pubitemid 28459654)
16. Lebrin F., Deckers M., Bertolino P., Ten Dijke P., TGF- β receptor function in the endothelium. Cardiovascular Research 2005 65 3 599 608 2-s2.0-12344273467 10.1016/j.cardiores.2004.10.036 (Pubitemid 40138980)
17. Maheshwari A., Kelly D. R., Nicola T., Ambalavanan N., Jain S. K., Murphyullrich J., Athar M., Shimamura M., Bhandari V., Aprahamian C., Dimmitt R. A., Serra R., Ohls R. K., TGF- β 2 suppresses macrophage cytokine production and mucosal inflammatory responses in the developing intestine. Gastroenterology 2011 140 1 242 253 2-s2.0-78650455673 10.1053/j.gastro.2010.09. 043
18. Gonzalo-Gil E., Criado G., Santiago B., Dotor J., Pablos M J. L., TGF-beta signalling is increased in rheumatoid synovium but TGF-beta blockade does not modify experimental arthritis. Clinical and Experimental Immunology 2013 2013 10.1111/cei.12179
19. Ho A., Lee P. H., Hsu Y. C., Sustained wnt/ β -catenin signaling rescues high glucose induction of transforming growth factor- β 1-mediated renal fibrosis. The American Journal of the Medical Sciences 2012 344 5 374 382
20. Position of the Polish Diabetes Association, Clinical recommendations for treatment of patients with diabetes. Journal of the Diabetes Poland Supl.A3-A7 2011 12
21. American Diabetes Association, Diagnosis and classification of diabetes. Diabetes Care 2010 33 supplement 1 S62 S69 10.2337/dc10-S062
22. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescent. Pediatrics 2004 114 555 576
23. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991 98 5 11 807 8822
24. Zorena K., Myśliwska J., Myśliwiec M., Balcerska A., Hak Ł., Lipowski P., Raczyńska K., Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children. Mediators of Inflammation 2007 2007 2-s2.0-34250836383 10.1155/2007/92196 92196 (Pubitemid 46987648)
25. Simó-Servat O., Hernández C., Simó R., Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy. Mediators of Inflammation 2012 2012 11 872978 10.1155/2012/872978
26. Gverović Antunica A., Karaman K., Znaor L., Sapunar A., Buško V., Puzović V., IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients. Graefe's Archive for Clinical and Experimental Ophthalmology 2012 250 6 815 821 2-s2.0-84855364010 10.1007/s00417-011-1905-4
27. Abu El-Asrar A. M., Nawaz M. I., Kangave D., Siddiquei M. M., Geboes K., Angiogenic and vasculogenic factors in the vitreous from patients with proliferative diabetic retinopathy. Journal of Diabetes Research 2013 2013 9 539658 10.1155/2013/539658
28. Zorena K., Malinowska E., Raczyńska D., Myśliwiec M., Raczyńska K., Serum concentrations of transforming growth factor-Beta 1 in predicting the occurrence of diabetic retinopathy in juvenile patients with type 1 diabetes mellitus. Journal of Diabetes Research 2013 2013 6 614908 10.1155/2013/614908
29. Mauer S. M., Steffes M. W., Ellis E. N., Structural-functional relationships in diabetic nephropathy. Journal of Clinical Investigation 1984 74 4 1143 1155 2-s2.0-0021715307 (Pubitemid 15210185)
30. Loukovaara S., Robciuc A., Holopainen J. M., Lehti K., Pessi T., Liinamaa J., Kukkonen K. T., Jauhiainen M., Koli K., Keski-Oja J., Immonen I., Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGF β 1 in diabetic eyes undergoing vitrectomy. Acta Ophthalmologica 2013 91 6 531 539 10.1111/j.1755-3768.2012.02473.x